leisure time -WSS

leisure time

author：leisure time 2025-10-02 22:27:59 - browse：61

Two people stare at a keyhole in a human head in between them, as the short-haired person on the left holds a key — first opinion coverage from STAT — Adobe

In many ways, psychiatry is still flying blind. People experiencing mental health conditions are prescribed various drugs until one (or a combination) finally works — a painful process that can take years. As a psychiatrist and neuroscientist, I became increasingly impatient and frustrated with this ineffective way of treating patients. This guided the core question behind my research: Can biology explain how people with the same psychiatric disorder respond differently to the same treatment?

Since I first began exploring this question more than a decade ago, mental illness has become a global epidemic. Despite significant efforts, progress in psychiatric drug development has remained disappointingly slow. There have been a few notable approvals in recent years, and a renewal of interest by Big Pharma, following a retreat from psychiatric research in the mid to late 2000s. But the landscape remains predominantly marked by failures and a dry drug development pipeline. Approved drugs follow the same pattern of prescribing via guesswork, with most patients not responding to a given drug. This cycle of trial-and-error drug development producing trial-and-error treatment arises from a simple source: We have not systematized a process for learning from our failures and successes.

Related: A ‘renaissance in neuroscience’ could deliver a fresh crop of psychiatric medicines

For example, take depression: While the rise of selective serotonin reuptake inhibitors (SSRIs) in the 1980s and 1990s seemed to provide a solution, seminal studies in the 2000s exposed fundamental limitations of our treatment options. Antidepressants are widely prescribed, but their efficacy relative to placebo is modest.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Maui funeral service workers on devastation of fires: 'I'm in shock'

knowledge

WSS

Pharma budget tightening trickles down to Doximity

Our daughter's deadly disease: trisomy 18. We wanted to protect her

Who are the detained American citizens released from prison in Iran?

An innovative path out of biotech’s “valley of death”

The perfect storm of weather conditions that led to the devastating wildfires in Maui

TB outbreak tied to bone grafts underscores testing shortcomings

leisure time

leisure time

Related: A ‘renaissance in neuroscience’ could deliver a fresh crop of psychiatric medicines

focus

Medical leaders decry Supreme Court decision on affirmative action

FDA official pushes for dedicated emerging pathogens team

United colonoscopy coverage change 'may cost lives,' doctors say

Novo acquires Inversago for up to $1 billion

Tori Bowie and the unacceptable rates of Black maternal death

Providers still hesitate to prescribe buprenorphine, study finds

Wildfire smoke exposes gaps in outdoor worker protections

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Guidelines to prevent youth baseball injuries need more muscle

CDC overhauls leadership of center that led response to Covid

entertainment

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

Some of the ways extreme heat will change life as we know it

Will.i.am, Britney Spears release new single, 'Mind Your Business'

Covid's long

Pharma budget tightening trickles down to Doximity

Target recalls 2.2 million additional candles due to laceration, burn hazards

focus

knowledge

leisure time

knowledge